New indication joins a series of single-agent and combination treatments for various cancers.
Modern Medicine News
FDA’s approval of the first generic version of Copaxone for treating patients with relapsing forms of multiple sclerosis has industry insiders contemplating the impact on the generics market as well as payer coverage strategies.
More than 750 government and private ACOs are now in place, helping healthcare transition away from fee-for-service. Find out what's working and what's planned for the future.
Consensus is building on the promise of genetic testing and other technological advances to help individualize testing, prevention and treatment for better outcomes.
Consumers searching for health information on Google will now see results from Mayo Clinic in a feature box at the top of the return screen.
Research has been given a shot in the arm by Apple Corp, which recently expanded the use of ResearchKit to include clinical trials.
The number of deaths from prescription pain relievers dropped 5% in 2012, and new tools are helping in the fight against opioid abuse.
UnitedHealth Group’s announcement that its free-standing pharmacy care services business, OptumRx, will merge with Catamaran Corp., the fourth largest pharmacy benefit manager in the U.S., makes sense, according to industry experts.